Targeting the wingless signaling pathway with natural compounds as chemopreventive or chemotherapeutic agents

Current Pharmaceutical Biotechnology

Volumn 13, Issue 1, 2012, Pages 245-254

  Teiten, Marie Hélène ^a   Gaascht, François ^a   Dicato, Mario ^a   Diederich, Marc ^a  

^a LABORATOIRE DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE DU CANCER   (Luxembourg)

Author keywords

Beta catenin; Cancer; Chemoprevention; Chemotherapy; Natural compounds; Wingless signaling pathway

Indexed keywords

ANTHOCYANIN; ANTINEOPLASTIC AGENT; APIGENIN; BLACK TEA EXTRACT; CAFFEIC ACID; CAFFEIC ACID PHENETHYL ESTER; COUMARIC ACID; CURCUMIN; DEMETHOXYCURCUMIN; DIDEMETHOXYCURCUMIN; ELLAGIC ACID; ELLAGITANNIN; EPIGALLOCATECHIN GALLATE; FERULIC ACID; FISETIN; FLAVANONE; FLAVONOID; GREEN TEA EXTRACT; HYDROXYBENZOIC ACID; IONOMYCIN; ISOFLAVONE; LUPEOL; NARINGENIN; PHENOL DERIVATIVE; PKF 222 815; QUERCETIN; RESVERATROL; TETRAHYDROCURCUMIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; WNT1 PROTEIN;

ACTIN FILAMENT; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BERRY; BREAST CANCER; CALCIUM SIGNALING; CARCINOGENESIS; CELL ADHESION; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL MEMBRANE; CELL POLARITY; CELL PROLIFERATION; CELL SURVIVAL; CHEMOPROPHYLAXIS; COLON CARCINOGENESIS; COLON CARCINOMA; COLORECTAL TUMOR; CURCUMA LONGA; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVITY; FAMILIAL POLYPOSIS; GENE EXPRESSION; GENETIC TRANSCRIPTION; HERBA EPIMEDII; HUMAN; MEDICINAL PLANT; MOLECULARLY TARGETED THERAPY; NEOPLASM; NONHUMAN; OSTEOSARCOMA; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TEA; TRANSCRIPTION REGULATION;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS; BIOLOGICAL AGENTS; HUMANS; NEOPLASMS; WNT SIGNALING PATHWAY;

CAMELLIA SINENSIS;

EID: 84855824494     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920112798868593     Document Type: Article

References (118)

1. Fernandez, E.; Gallus, S.; La Vecchia, C. Nutrition and cancer risk: an overview. J. Br. Menopause Soc., 2006, 12(4), 139-142.
2. La Vecchia, C. Association between Mediterranean dietary patterns and cancer risk. Nutr. Rev., 2009, 67 (Suppl. 1), (S126-129).
3. Surh, Y.J. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer, 2003, 3(10), 768-780.
4. Kundu, J.K.; Choi, K.Y.; Surh, Y.J. beta-Catenin-mediated signaling: a novel molecular target for chemoprevention with antiinflammatory substances. Biochim. Biophys. Acta., 2006, 1765(1), 14-24.
5. Clevers, H. Wnt/beta-catenin signaling in development and disease. Cell, 2006, 127(3), 469-480.
6. Polakis, P. The many ways of Wnt in cancer. Curr. Opin. Genet. Dev., 2007, 17(1), 45-51.
7. Camilli, T.C.; Weeraratna, A.T. Striking the target in Wnt-y conditions: Intervening in Wnt signaling during cancer progression. Biochem. Pharmacol., 2010, 80(5): 702-711.
8. Kikuchi, A.; Kishida, S.; Yamamoto, H. Regulation of Wnt signaling by protein-protein interaction and post-translational modifications. Exp. Mol. Med., 2006, 38(1), 1-10.
9. Su, Y.; Fu, C.; Ishikawa, S.; Stella, A.; Kojima, M.; Shitoh, K.; Schreiber, E.M.; Day, B.W.; Liu, B. APC is essential for targeting phosphorylated beta-catenin to the SCFbeta-TrCP ubiquitin ligase. Mol. Cell, 2008, 32(5), 652-661.
10. Liu, C.; Li, Y.; Semenov, M.; Han, C.; Baeg, G.H.; Tan, Y.; Zhang, Z.; Lin, X.; He, X. Control of beta-catenin phosphorylation/ degradation by a dual-kinase mechanism. Cell, 2002, 108(6), 837-847.
11. Hart, M.; Concordet, J.P.; Lassot, I.; Albert, I.; del los Santos, R.; Durand, H.; Perret, C.; Rubinfeld, B.; Margottin, F.; Benarous, R.; Polakis, P. The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell. Curr. Biol., 1999, 9(4), 207-210.
12. Aberle, H.; Bauer, A.; Stappert, J.; Kispert, A.; Kemler, R. betacatenin is a target for the ubiquitin-proteasome pathway. EMBO J., 1997, 16(13), 3797-3804.
13. Hurlstone, A.; Clevers, H. T-cell factors: turn-ons and turn-offs. EMBO J., 2002, 21(10), 2303-2311.
14. Sampson, E.M.; Haque, Z.K.; Ku, M.C.; Tevosian, S.G.; Albanese, C.; Pestell, R.G.; Paulson, K.E.; Yee, A.S. Negative regulation of the Wnt-beta-catenin pathway by the transcriptional repressor HBP1. EMBO J., 2001, 20(16), 4500-4511.
15. Arce, L.; Pate, K.T.; Waterman, M.L. Groucho binds two conserved regions of LEF-1 for HDAC-dependent repression. BMC Cancer, 2009, 9, 159.
16. He, X.; Semenov, M.; Tamai, K.; Zeng, X. LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development, 2004, 131(8), 1663-1677.
17. Zeng, X.; Tamai, K.; Doble, B.; Li, S.; Huang, H.; Habas, R.; Okamura, H.; Woodgett, J.; He, X. A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation. Nature, 2005, 438(7069), 873-877.
18. Townsley, F.M.; Cliffe, A.; Bienz, M. Pygopus and Legless target Armadillo/beta-catenin to the nucleus to enable its transcriptional co-activator function. Nat. Cell Biol., 2004, 6(7), 626-633.
19. Kramps, T.; Peter, O.; Brunner, E.; Nellen, D.; Froesch, B.; Chatterjee, S.; Murone, M.; Zullig, S.; Basler, K. Wnt/wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear beta-catenin-TCF complex. Cell, 2002, 109(1), 47-60.
20. Behrens, J.; von Kries, J.P.; Kuhl, M.; Bruhn, L.; Wedlich, D.; Grosschedl, R.; Birchmeier, W. Functional interaction of betacatenin with the transcription factor LEF-1. Nature, 1996, 382(6592), 638-642.
21. Hecht, A.; Vleminckx, K.; Stemmler, M.P.; van Roy, F.; Kemler, R. The p300/CBP acetyltransferases function as transcriptional coactivators of beta-catenin in vertebrates. EMBO J., 2000, 19(8), 1839-1850.
22. Sato, A.; Khadka, D.K.; Liu, W.; Bharti, R.; Runnels, L.W.; Dawid, I.B.; Habas, R. Profilin is an effector for Daam1 in noncanonical Wnt signaling and is required for vertebrate gastrulation. Development, 2006, 133(21), 4219-4231.
23. Katoh, M. WNT/PCP signaling pathway and human cancer (review). Oncol. Rep., 2005, 14(6), 1583-1588.
24. Qian, D.; Jones, C.; Rzadzinska, A.; Mark, S.; Zhang, X.; Steel, K.P.; Dai, X.; Chen, P. Wnt5a functions in planar cell polarity regulation in mice. Dev. Biol., 2007, 306(1), 121-133.
25. Yamamoto, S.; Nishimura, O.; Misaki, K.; Nishita, M.; Minami, Y.; Yonemura, S.; Tarui, H.; Sasaki, H. Cthrc1 selectively activates the planar cell polarity pathway of Wnt signaling by stabilizing the Wnt-receptor complex. Dev. Cell, 2008, 15(1), 23-36.
26. Habas, R.; Kato, Y.; He, X. Wnt/Frizzled activation of Rho regulates vertebrate gastrulation and requires a novel Formin homology protein Daam1. Cell, 2001, 107(7), 843-854.
27. Winter, C.G.; Wang, B.; Ballew, A.; Royou, A.; Karess, R.; Axelrod, J.D.; Luo, L. Drosophila Rho-associated kinase (Drok) links Frizzled-mediated planar cell polarity signaling to the actin cytoskeleton. Cell, 2001, 105(1), 81-91.
28. Yamanaka, H.; Moriguchi, T.; Masuyama, N.; Kusakabe, M.; Hanafusa, H.; Takada, R.; Takada, S.; Nishida, E. JNK functions in the non-canonical Wnt pathway to regulate convergent extension movements in vertebrates. EMBO Rep., 2002, 3(1), 69-75.
29. Kurayoshi, M.; Oue, N.; Yamamoto, H.; Kishida, M.; Inoue, A.; Asahara, T.; Yasui, W.; Kikuchi, A. Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. Cancer Res., 2006, 66(21), 10439-10448.
30. Wang, Y. Wnt/Planar cell polarity signaling: a new paradigm for cancer therapy. Mol. Cancer Ther., 2009, 8(8), 2103-2109.
31. Kohn, A.D.; Moon, R.T. Wnt and calcium signaling: beta-cateninindependent pathways. Cell Calcium, 2005, 38(3-4), 439-446.
32. Kuhl, M. The WNT/calcium pathway: biochemical mediators, tools and future requirements. Front. Biosci., 2004, 9, 967-974.
33. Slusarski, D.C.; Corces, V.G.; Moon, R.T. Interaction of Wnt and a Frizzled homologue triggers G-protein-linked phosphatidylinositol signalling. Nature, 1997, 390(6658), 410-413.
34. Streb, H.; Irvine, R.F.; Berridge, M.J.; Schulz, I. Release of Ca2+ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate. Nature, 1983, 306(5938), 67-69.
35. Kuhl, M.; Sheldahl, L.C.; Malbon, C.C.; Moon, R.T. Ca(2+)/ calmodulin-dependent protein kinase II is stimulated by Wnt and Frizzled homologs and promotes ventral cell fates in Xenopus. J. Biol. Chem., 2000, 275(17), 12701-12711.
36. Sheldahl, L.C.; Park, M.; Malbon, C.C.; Moon, R.T. Protein kinase C is differentially stimulated by Wnt and Frizzled homologs in a Gprotein-dependent manner. Curr. Biol., 1999, 9(13), 695-698.
37. Saneyoshi, T.; Kume, S.; Amasaki, Y.; Mikoshiba, K. The Wnt/calcium pathway activates NF-AT and promotes ventral cell fate in Xenopus embryos. Nature, 2002, 417(6886), 295-299.
38. Ishitani, T.; Ninomiya-Tsuji, J.; Nagai, S.; Nishita, M.; Meneghini, M.; Barker, N.; Waterman, M.; Bowerman, B.; Clevers, H.; Shibuya, H.; Matsumoto, K. The TAK1-NLK-MAPK-related pathway antagonizes signalling between beta-catenin and transcription factor TCF. Nature, 1999, 399(6738), 798-802.
39. Schlessinger, K.; McManus, E.J.; Hall, A. Cdc42 and noncanonical Wnt signal transduction pathways cooperate to promote cell polarity. J. Cell Biol., 2007, 178(3), 355-361.
40. Courtwright, A.; Siamakpour-Reihani, S.; Arbiser, J.L.; Banet, N.; Hilliard, E.; Fried, L.; Livasy, C.; Ketelsen, D.; Nepal, D.B.; Perou, C.M.; Patterson, C.; Klauber-Demore, N. Secreted frizzle-related protein 2 stimulates angiogenesis via a calcineurin/NFAT signaling pathway. Cancer Res., 2009, 69(11), 4621-4628.
41. Dihlmann, S.; von Knebel Doeberitz, M. Wnt/beta-catenin-pathway as a molecular target for future anti-cancer therapeutics. Int. J. Cancer, 2005, 113(4), 515-524.
42. Gehrke, I.; Gandhirajan, R.K.; Kreuzer, K.A. Targeting the WNT/ beta-catenin/TCF/LEF1 axis in solid and haematological cancers: Multiplicity of therapeutic options. Eur. J. Cancer, 2009, 45(16), 2759-2767.
43. Herbst, A.; Kolligs, F.T. Wnt signaling as a therapeutic target for cancer. Methods Mol. Biol., 2007, 361, 63-91.
44. Liu, J.; Stevens, J.; Matsunami, N.; White, R.L. Targeted degradation of beta-catenin by chimeric F-box fusion proteins. Biochem. Biophys. Res. Commun., 2004, 313(4), 1023-1029.
45. Brunori, M.; Malerba, M.; Kashiwazaki, H.; Iggo, R. Replicating adenoviruses that target tumors with constitutive activation of the wnt signaling pathway. J. Virol., 2001, 75(6), 2857-2865.
46. Chen, R.H.; McCormick, F. Selective targeting to the hyperactive beta-catenin/T-cell factor pathway in colon cancer cells. Cancer Res., 2001, 61(11), 4445-4449.
47. You, L.; He, B.; Xu, Z.; Uematsu, K.; Mazieres, J.; Fujii, N.; Mikami, I.; Reguart, N.; McIntosh, J.K.; Kashani-Sabet, M.; McCormick, F.; Jablons, D.M. An anti-Wnt-2 monoclonal antibody induces apoptosis in malignant melanoma cells and inhibits tumor growth. Cancer Res., 2004, 64(15), 5385-5389.
48. Nagayama, S.; Fukukawa, C.; Katagiri, T.; Okamoto, T.; Aoyama, T.; Oyaizu, N.; Imamura, M.; Toguchida, J.; Nakamura, Y. Therapeutic potential of antibodies against FZD 10, a cell-surface protein, for synovial sarcomas. Oncogene, 2005, 24(41), 6201-6212.
49. You, L.; Kim, J.; He, B.; Xu, Z.; McCormick, F.; Jablons, D.M. Wnt-1 signal as a potential cancer therapeutic target. Drug News Perspect., 2006, 19(1), 27-31.
50. Roh, H.; Green, D.W.; Boswell, C.B.; Pippin, J.A.; Drebin, J.A. Suppression of beta-catenin inhibits the neoplastic growth of APCmutant colon cancer cells. Cancer Res., 2001, 61(17), 6563-6568.
51. Verma, U.N.; Surabhi, R.M.; Schmaltieg, A.; Becerra, C.; Gaynor, R.B. Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells. Clin. Cancer Res., 2003, 9(4), 1291-1300.
52. Fujise, T.; Iwakiri, R.; Kakimoto, T.; Shiraishi, R.; Sakata, Y.; Wu, B.; Tsunada, S.; Ootani, A.; Fujimoto, K. Long-term feeding of various fat diets modulates azoxymethane-induced colon carcino genesis through Wnt/beta-catenin signaling in rats. Am. J. Physiol. Gastrointest. Liver Physiol., 2007, 292(4), G1150-1156.
53. Thangapazham, R.L.; Sharma, A.; Maheshwari, R.K. Multiple molecular targets in cancer chemoprevention by curcumin. AAPS J., 2006, 8(3), E443-449.
54. Teiten, M.H.; Eifes, S.; Dicato, M.; Diederich, M. Curcumin-the paradigm of multi-target natural compound with applications in cancer prevention and treatment Toxins, 2010, 2(1), 128-162.
55. Park, C.H.; Hahm, E.R.; Park, S.; Kim, H.K.; Yang, C.H. The inhibitory mechanism of curcumin and its derivative against betacatenin/ Tcf signaling. FEBS Lett., 2005, 579(13), 2965-2971.
56. Narayan, S. Curcumin, a multi-functional chemopreventive agent, blocks growth of colon cancer cells by targeting beta-cateninmediated transactivation and cell-cell adhesion pathways. J. Mol. Histol., 2004, 35(3), 301-307.
57. Ryu, M.J.; Cho, M.; Song, J.Y.; Yun, Y.S.; Choi, I.W.; Kim, D.E.; Park, B.S.; Oh, S. Natural derivatives of curcumin attenuate the Wnt/beta-catenin pathway through down-regulation of the transcriptional coactivator p300. Biochem. Biophys. Res. Commun., 2008, 377(4), 1304-1308.
58. Jaiswal, A.S.; Marlow, B.P.; Gupta, N.; Narayan, S. Beta-cateninmediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells. Oncogene, 2002, 21(55), 8414-8427.
59. Mahmoud, N.N.; Carothers, A.M.; Grunberger, D.; Bilinski, R.T.; Churchill, M.R.; Martucci, C.; Newmark, H.L.; Bertagnolli, M.M. Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis, 2000, 21(5), 921-927.
60. Leow, P.C.; Tian, Q.; Ong, Z.Y.; Yang, Z.; Ee, P.L. Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/beta-catenin antagonists against human osteosarcoma cells. Invest. New Drugs, 2010, 2(6), 766-782.
61. Yan, C.; Jamaluddin, M.S.; Aggarwal, B.; Myers, J.; Boyd, D.D. Gene expression profiling identifies activating transcription factor 3 as a novel contributor to the proapoptotic effect of curcumin. Mol. Cancer Ther., 2005, 4(2), 233-241.
62. Prasad, C.P.; Rath, G.; Mathur, S.; Bhatnagar, D.; Ralhan, R. Potent growth suppressive activity of curcumin in human breast cancer cells: Modulation of Wnt/beta-catenin signaling. Chem. Biol. Interact., 2009, 181(2), 263-271.
63. Kakarala, M.; Brenner, D.E.; Korkaya, H.; Cheng, C.; Tazi, K.; Ginestier, C.; Liu, S.; Dontu, G.; Wicha, M.S. Targeting breast stem cells with the cancer preventive compounds curcumin and piperine. Breast Cancer Res. Treat., 2010, 122(3), 777-785.
64. Dashwood, W.M.; Orner, G.A.; Dashwood, R.H. Inhibition of betacatenin/ Tcf activity by white tea, green tea, and epigallocatechin-3-gallate (EGCG): minor contribution of H(2)O(2) at physiologically relevant EGCG concentrations. Biochem. Biophys. Res. Commun., 2002, 296(3), 584-588.
65. Dashwood, W.M.; Carter, O.; Al-Fageeh, M.; Li, Q.; Dashwood, R.H. Lysosomal trafficking of beta-catenin induced by the tea polyphenol epigallocatechin-3-gallate. Mutat. Res., 2005, 591(1-2), 161-172.
66. Orner, G.A.; Dashwood, W.M.; Blum, C.A.; Diaz, G.D.; Li, Q.; Al-Fageeh, M.; Tebbutt, N.; Heath, J.K.; Ernst, M.; Dashwood, R.H. Response of Apc(min) and A33 (delta N beta-cat) mutant mice to treatment with tea, sulindac, and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Mutat. Res., 2002, 506-507, 121-127.
67. Ju, J.; Hong, J.; Zhou, J.N.; Pan, Z.; Bose, M.; Liao, J.; Yang, G.Y.; Liu, Y.Y.; Hou, Z.; Lin, Y.; Ma, J.; Shih, W.J.; Carothers, A.M.; Yang, C.S. Inhibition of intestinal tumorigenesis in Apcmin/+ mice by (-)-epigallocatechin-3-gallate, the major catechin in green tea. Cancer Res., 2005, 65(22), 10623-10631.
68. Issa, A.Y.; Volate, S.R.; Muga, S.J.; Nitcheva, D.; Smith, T.; Wargovich, M.J. Green tea selectively targets initial stages of intestinal carcinogenesis in the AOM-ApcMin mouse model. Carcinogenesis, 2007, 28(9), 1978-1984.
69. Gao, Z.; Xu, Z.; Hung, M.S.; Lin, Y.C.; Wang, T.; Gong, M.; Zhi, X.; Jablon, D.M.; You, L. Promoter demethylation of WIF-1 by epigallocatechin-3-gallate in lung cancer cells. Anticancer Res., 2009, 29(6), 2025-2030.
70. Mazieres, J.; He, B.; You, L.; Xu, Z.; Lee, A.Y.; Mikami, I.; Reguart, N.; Rosell, R.; McCormick, F.; Jablons, D.M. Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer. Cancer Res., 2004, 64(14), 4717-4720.
71. Kim, J.; Zhang, X.; Rieger-Christ, K.M.; Summerhayes, I.C.; Wazer, D.E.; Paulson, K.E.; Yee, A.S. Suppression of Wnt signaling by the green tea compound (-)-epigallocatechin 3-gallate (EGCG) in invasive breast cancer cells. Requirement of the transcriptional repressor HBP1. J. Biol. Chem., 2006, 281(16), 10865-10875.
72. Liu, L.; Lai, C.Q.; Nie, L.; Ordovas, J.; Band, M.; Moser, L.; Meydani, M. The modulation of endothelial cell gene expression by green tea polyphenol-EGCG. Mol. Nutr. Food Res., 2008, 52(10), 1182-1192.
73. Patel, R.; Ingle, A.; Maru, G.B. Polymeric black tea polyphenols inhibit 1,2-dimethylhydrazine induced colorectal carcinogenesis by inhibiting cell proliferation via Wnt/beta-catenin pathway. Toxicol. Appl. Pharmacol., 2008, 227(1), 136-146.
74. Song, S.; Krishnan, K.; Liu, K.; Bresalier, R.S. Polyphenon E inhibits the growth of human Barrett's and aerodigestive adenocarcinoma cells by suppressing cyclin D1 expression. Clin. Cancer Res., 2009, 15(2), 622-631.
75. Joe, A.K.; Liu, H.; Suzui, M.; Vural, M.E.; Xiao, D.; Weinstein, I.B. Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin. Cancer Res., 2002, 8(3), 893-903.
76. Hope, C.; Planutis, K.; Planutiene, M.; Moyer, M.P.; Johal, K.S.; Woo, J.; Santoso, C.; Hanson, J.A.; Holcombe, R.F. Low concentrations of resveratrol inhibit Wnt signal throughput in colonderived cells: implications for colon cancer prevention. Mol. Nutr. Food Res., 2008, 52 Suppl. 1, (S52-61).
77. Paul, S.; Decastro, A.; Lee, H.J.; Smolarek, A.K.; So, J.Y.; Simi, B.; Wang, C.X.; Zhou, R.; Rimando, A.M.; Suh, N. Dietary intake of pterostilbene, a constituent of blueberries, inhibits the {beta}-catenin/p65 downstream signaling pathway and colon carcinogenesis in rats. Carcinogenesis, 2010, 31(7), 1272-1278.
78. Zhou, H.; Shang, L.; Li, X.; Zhang, X.; Gao, G.; Guo, C.; Chen, B.; Liu, Q.; Gong, Y.; Shao, C. Resveratrol augments the canonical Wnt signaling pathway in promoting osteoblastic differentiation of multipotent mesenchymal cells. Exp. Cell Res., 2009, 315(17), 2953-2962.
79. Orsolic, N.; Terzic, S.; Mihaljevic, Z.; Sver, L.; Basic, I. Effects of local administration of propolis and its polyphenolic compounds on tumor formation and growth. Biol. Pharm. Bull., 2005, 28(10), 1928-1933.
80. Kuo, H.C.; Kuo, W.H.; Lee, Y.J.; Lin, W.L.; Chou, F.P.; Tseng, T.H. Inhibitory effect of caffeic acid phenethyl ester on the growth of C6 glioma cells in vitro and in vivo. Cancer Lett., 2006, 234(2), 199-208.
81. Liao, H.F.; Chen, Y.Y.; Liu, J.J.; Hsu, M.L.; Shieh, H.J.; Liao, H.J.; Shieh, C.J.; Shiao, M.S.; Chen, Y.J. Inhibitory effect of caffeic acid phenethyl ester on angiogenesis, tumor invasion, and metastasis. J. Agric. Food Chem., 2003, 51(27), 7907-7912.
82. He, Y.J.; Liu, B.H.; Xiang, D.B.; Qiao, Z.Y.; Fu, T.; He, Y.H. Inhibitory effect of caffeic acid phenethyl ester on the growth of SW480 colorectal tumor cells involves beta-catenin associated signaling pathway down-regulation. World J. Gastroenterol., 2006, 12(31), 4981-4985.
83. Xiang, D.; Wang, D.; He, Y.; Xie, J.; Zhong, Z.; Li, Z. Caffeic acid phenethyl ester induces growth arrest and apoptosis of colon cancer cells via the beta-catenin/T-cell factor signaling. Anticancer. Drugs, 2006, 17(7), 753-762.
84. Wang, D.; Xiang, D.B.; He, Y.J.; Li, Z.P.; Wu, X.H.; Mou, J.H.; Xiao, H.L.; Zhang, Q.H. Effect of caffeic acid phenethyl ester on proliferation and apoptosis of colorectal cancer cells in vitro. World J. Gastroenterol., 2005, 11(26), 4008-4012.
85. Zikri, N.N.; Riedl, K.M.; Wang, L.S.; Lechner, J.; Schwartz, S.J.; Stoner, G.D. Black raspberry components inhibit proliferation, induce apoptosis, and modulate gene expression in rat esophageal epithelial cells. Nutr. Cancer, 2009, 61(6), 816-826.
86. Stoner, G.D.; Wang, L.S.; Casto, B.C. Laboratory and clinical studies of cancer chemoprevention by antioxidants in berries. Carcinogenesis, 2008, 29(9), 1665-1674.
87. Rajakangas, J.; Misikangas, M.; Paivarinta, E.; Mutanen, M. Chemoprevention by white currant is mediated by the reduction of nuclear beta-catenin and NF-kappaB levels in Min mice adenomas. Eur. J. Nutr., 2008, 47(3), 115-122.
88. Misikangas, M.; Pajari, A.M.; Paivarinta, E.; Oikarinen, S.I.; Rajakangas, J.; Marttinen, M.; Tanayama, H.; Torronen, R.; Mutanen, M. Three Nordic berries inhibit intestinal tumorigenesis in multiple intestinal neoplasia/+ mice by modulating beta-catenin signaling in the tumor and transcription in the mucosa. J. Nutr., 2007, 137(10), 2285-2290.
89. Mutanen, M.; Pajari, A.M.; Paivarinta, E.; Misikangas, M.; Rajakangas, J.; Marttinen, M.; Oikarinen, S. Berries as chemopreventive dietary constituents--a mechanistic approach with the ApcMin/+ mouse. Asia Pac. J. Clin. Nutr., 2008, 17 Suppl. 1, (123-125).
90. Saleem, M.; Murtaza, I.; Tarapore, R.S.; Suh, Y.; Adhami, V.M.; Johnson, J.J.; Siddiqui, I.A.; Khan, N.; Asim, M.; Hafeez, B.B.; Shekhani, M.T.; Li, B.; Mukhtar, H. Lupeol inhibits proliferation of human prostate cancer cells by targeting beta-catenin signaling. Carcinogenesis, 2009, 30(5), 808-817.
91. Lee, S.H.; Cekanova, M.; Baek, S.J. Multiple mechanisms are involved in 6-gingerol-induced cell growth arrest and apoptosis in human colorectal cancer cells. Mol. Carcinog., 2008, 47(3), 197-208.
92. Yamaguchi, K.; Liggett, J.L.; Kim, N.C.; Baek, S.J. Antiproliferative effect of horehound leaf and wild cherry bark extracts on human colorectal cancer cells. Oncol. Rep., 2006, 15(1), 275-281.
93. Sharma, M.; Li, L.; Celver, J.; Killian, C.; Kovoor, A.; Seeram, N.P. Effects of Fruit Ellagitannin Extracts, Ellagic Acid, and Their Colonic Metabolite, Urolithin A, on Wnt Signaling (dagger). J. Agric. Food Chem., 2010, 58(7), 3965-3969.
94. Park, C.H.; Chang, J.Y.; Hahm, E.R.; Park, S.; Kim, H.K.; Yang, C.H. Quercetin, a potent inhibitor against beta-catenin/Tcf signaling in SW480 colon cancer cells. Biochem. Biophys. Res. Commun., 2005, 328(1), 227-234.
95. Shan, B.E.; Wang, M.X.; Li, R.Q. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway. Cancer Invest., 2009, 27(6), 604-612.
96. Suh, Y.; Afaq, F.; Johnson, J.J.; Mukhtar, H. A plant flavonoid fisetin induces apoptosis in colon cancer cells by inhibition of COX2 and Wnt/EGFR/NF-kappaB-signaling pathways. Carcinogenesis, 2009, 30(2), 300-307.
97. Amado, N.G.; Cerqueira, D.M.; Menezes, F.S.; da Silva, J.F.; Neto, V.M.; Abreu, J.G. Isoquercitrin isolated from Hyptis fasciculata reduces glioblastoma cell proliferation and changes beta-catenin cellular localization. Anticancer. Drugs, 2009, 20(7), 543-552.
98. Park, C.H.; Hahm, E.R.; Lee, J.H.; Jung, K.C.; Yang, C.H. Inhibition of beta-catenin-mediated transactivation by flavanone in AGS gastric cancer cells. Biochem. Biophys. Res. Commun., 2005, 331(4), 1222-1228.
99. Lee, J.H.; Park, C.H.; Jung, K.C.; Rhee, H.S.; Yang, C.H. Negative regulation of beta-catenin/Tcf signaling by naringenin in AGS gastric cancer cell. Biochem. Biophys. Res. Commun., 2005, 335(3), 771-776.
100. Shukla, S.; MacLennan, G.T.; Flask, C.A.; Fu, P.; Mishra, A.; Resnick, M.I.; Gupta, S. Blockade of beta-catenin signaling by plant flavonoid apigenin suppresses prostate carcinogenesis in TRAMP mice. Cancer Res., 2007, 67(14), 6925-6935.
101. Su, Y.; Simmen, R.C. Soy isoflavone genistein upregulates epithelial adhesion molecule E-cadherin expression and attenuates betacatenin signaling in mammary epithelial cells. Carcinogenesis, 2009, 30(2), 331-339.
102. Zhang, J.F.; Li, G.; Chan, C.Y.; Meng, C.L.; Lin, M.C.; Chen, Y.C.; He, M.L.; Leung, P.C.; Kung, H.F. Flavonoids of Herba Epimedii regulate osteogenesis of human mesenchymal stem cells through BMP and Wnt/beta-catenin signaling pathway. Mol. Cell. Endocrinol., 2010, 314(1), 70-74.
103. Dashwood, R.H. Indole-3-carbinol: anticarcinogen or tumor promoter in brassica vegetables? Chem. Biol. Interact., 1998, 110(1-2), 1-5.
104. Blum, C.A.; Tanaka, T.; Zhong, X.; Li, Q.; Dashwood, W.M.; Pereira, C.; Xu, M.; Dashwood, R.H. Mutational analysis of Ctnnb1 and Apc in tumors from rats given 1,2-dimethylhydrazine or 2-amino-3-methylimidazo[4,5-f]quinoline: mutational 'hotspots' and the relative expression of beta-catenin and c-jun. Mol. Carcinog., 2003, 36(4), 195-203.
105. Wang, R.; Dashwood, W.M.; Bailey, G.S.; Williams, D.E.; Dashwood, R.H. Tumors from rats given 1,2-dimethylhydrazine plus chlorophyllin or indole-3-carbinol contain transcriptional changes in beta-catenin that are independent of beta-catenin mutation status. Mutat. Res., 2006, 601(1-2), 11-18.
106. Blum, C.A.; Xu, M.; Orner, G.A.; Dario Diaz, G.; Li, Q.; Dashwood, W.M.; Bailey, G.S.; Dashwood, R.H. Promotion versus suppression of rat colon carcinogenesis by chlorophyllin and chlorophyll: modulation of apoptosis, cell proliferation, and betacatenin/ Tcf signaling. Mutat. Res., 2003, 523-524, 217-223.
107. Song, G.Y.; Lee, J.H.; Cho, M.; Park, B.S.; Kim, D.E.; Oh, S. Decursin suppresses human androgen-independent PC3 prostate cancer cell proliferation by promoting the degradation of betacatenin. Mol. Pharmacol., 2007, 72(6), 1599-1606.
108. Bi, X.; Zhao, Y.; Fang, W.; Yang, W. Anticancer activity of Panax notoginseng extract 20(S)-25-OCH3-PPD: Targetting beta-catenin signalling. Clin. Exp. Pharmacol. Physiol., 2009, 36(11), 1074-1078.
109. Li, X.; Ohtsuki, T.; Koyano, T.; Kowithayakorn, T.; Ishibashi, M. New Wnt/beta-catenin signaling inhibitors isolated from Eleutherine palmifolia. Chem. Asian J., 2009, 4(4), 540-547.
110. Chung, H.; Jung, Y.M.; Shin, D.H.; Lee, J.Y.; Oh, M.Y.; Kim, H.J.; Jang, K.S.; Jeon, S.J.; Son, K.H.; Kong, G. Anticancer effects of wogonin in both estrogen receptor-positive and-negative human breast cancer cell lines in vitro and in nude mice xenografts. Int. J. Cancer, 2008, 122(4), 816-822.
111. Murillo, G.; Peng, X.; Torres, K.E.; Mehta, R.G. Deguelin inhibits growth of breast cancer cells by modulating the expression of key members of the Wnt signaling pathway. Cancer. Prev. Res. (Phila Pa), 2009, 2(11), 942-950.
112. Gwak, J.; Park, S.; Cho, M.; Song, T.; Cha, S.H.; Kim, D.E.; Jeon, Y.J.; Shin, J.G.; Oh, S. Polysiphonia japonica extract suppresses the Wnt/beta-catenin pathway in colon cancer cells by activation of NF-kappaB. Int. J. Mol. Med., 2006, 17(6), 1005-1010.
113. McCulloch, M.W.; Coombs, G.S.; Banerjee, N.; Bugni, T.S.; Cannon, K.M.; Harper, M.K.; Veltri, C.A.; Virshup, D.M.; Ireland, C.M. Psammaplin A as a general activator of cell-based signaling assays via HDAC inhibition and studies on some bromotyrosine derivatives. Bioorg. Med. Chem., 2009, 17(6), 2189-2198.
114. McCulloch, M.W.; Bugni, T.S.; Concepcion, G.P.; Coombs, G.S.; Harper, M.K.; Kaur, S.; Mangalindan, G.C.; Mutizwa, M.M.; Veltri, C.A.; Virshup, D.M.; Ireland, C.M. Carteriosulfonic acids A-C, GSK-3beta inhibitors from a Carteriospongia sp. J. Nat. Prod., 2009, 72(9), 1651-1656.
115. Lepourcelet, M.; Chen, Y.N.; France, D.S.; Wang, H.; Crews, P.; Petersen, F.; Bruseo, C.; Wood, A.W.; Shivdasani, R.A. Smallmolecule antagonists of the oncogenic Tcf/beta-catenin protein complex. Cancer Cell, 2004, 5(1), 91-102.
116. Wei, W.; Chua, M.S.; Grepper, S.; So, S. Small molecule antagonists of Tcf4/beta-catenin complex inhibit the growth of HCC cells in vitro and in vivo. Int. J. Cancer, 2010, 126(10), 2426-2436.
117. Park, C.H.; Hahm, E.R.; Lee, J.H.; Jung, K.C.; Rhee, H.S.; Yang, C.H. Ionomycin downregulates beta-catenin/Tcf signaling in colon cancer cell line. Carcinogenesis, 2005, 26(11), 1929-1933.
118. Zhang, Y.; Yeh, J.R.; Mara, A.; Ju, R.; Hines, J.F.; Cirone, P.; Griesbach, H.L.; Schneider, I.; Slusarski, D.C.; Holley, S.A.; Crews, C.M. A chemical and genetic approach to the mode of action of fumagillin. Chem. Biol., 2006, 13(9), 1001-1009.